Genome-wide DNA methylation profiling in infants born to gestational diabetes mellitus
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
BACKGROUND Offspring exposed to gestational diabetes mellitus (GDM) are at a high risk for metabolic diseases. The mechanisms behind the association between offspring exposed to GDM in utero and an increased risk of health consequences later in life remain unclear. The aim of this study was to clarify the changes in methylation levels in the foetuses of women with GDM and to explore the possible mechanisms linking maternal GDM with a high risk of metabolic diseases in offspring later in life. METHODS A genome-wide comparative methylome analysis on the umbilical cord blood of infants born to 30 women with GDM and 33 women with normal pregnancy was performed using Infinium HumanMethylation 450 BeadChip assays. A quantitative methylation analysis of 18 CpG dinucleotides was verified in the validation umbilical cord blood samples from 102 newborns exposed to GDM and 103 newborns who experienced normal pregnancy by MassARRAY EpiTYPER. RESULTS A total of 4485 differentially methylated sites (DMSs), including 2150 hypermethylated sites and 2335 hypomethylated sites, with a mean β-value difference of >0.05, were identified by the 450k array. Good agreement was observed between the massarray validation data and the 450k array data (R2 > 0.99; P < 0.0001). Thirty-seven CpGs (representing 20 genes) with a β-value difference of > 0.15 between the GDM and healthy groups were identified and showed potential as clinical biomarkers for GDM. "hsa04940: Type I diabetes mellitus" was the most significant Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, with a P-value = 3.20E-07 and 1.36E-02 in the hypermethylated and hypomethylated genepathway enrichment analyses, respectively. In the Gene Ontology (GO) pathway analyses, immune MHC (major histocompatibility complex)-related pathways and neuron development-related pathways were significantly enriched. CONCLUSIONS Our results suggest that GDM has epigenetic effects on genes that are preferentially involved in the Type I diabetes mellitus pathway, immune MHC-related pathways and neuron development-related pathways, with consequences on fetal growth and development, and provide supportive evidence that DNA methylation is involved in fetal metabolic programming.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular Mechanisms for Insulin Resistance in Normal Pregnancy and Gestational Diabetes
Barbour, L. A., McCurdy, C. E., Hernandez, T. L., Kirwan, J. P., Catalano, P. M., & Friedman, J. E. (2007) · Diabetes Care · doi:10.2337/dc07-s202 · Cited by 811
Association of Intrauterine Exposure to Maternal Diabetes and Obesity With Type 2 Diabetes in Youth
Dabelea, D., Mayer-Davis, E. J., Lamichhane, A. P., D'Agostino, R. B., Liese, A. D., Vehik, K. S., Narayan, K. M. V., Zeitler, P., & Hamman, R. F. (2008) · Diabetes Care · doi:10.2337/dc07-2417 · Cited by 415
Zhubi, A., Chen, Y., Dong, E., Cook, E. H., Guidotti, A., & Grayson, D. R. (2014) · Translational Psychiatry · doi:10.1038/tp.2013.123 · Cited by 154
Maternal Weight Gain in Women Who Develop Gestational Diabetes Mellitus
Gibson, K. S., Waters, T. P., & Catalano, P. M. (2012) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31824758e0 · Cited by 141
Yumei, W., Huixia, Y., Weiwei, Z., Hongyun, Y., Haixia, L., Jie, Y., & Cuilin, Z. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20140898 · Cited by 109
Impact of maternal diabetes on epigenetic modifications leading to diseases in the offspring
Vrachnis, N., Antonakopoulos, N., Iliodromiti, Z., Dafopoulos, K., Siristatidis, C., Pappa, K. I., Deligeoroglou, E., & Vitoratos, N. (2012) · Experimental Diabetes Research · doi:10.1155/2012/538474 · Cited by 103
Cited by
Epigenetic Programming and Fetal Metabolic Programming
Zhu, Z., Cao, F., & Li, X. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00764 · Cited by 158
Chen, Z., Gong, L., Zhang, P., Li, Y., Liu, B., Zhang, L., Zhuang, J., & Xiao, D. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.33044 · Cited by 63
“Previous studies have shown that GDM exposure could alter global and gene-specific DNA methylation profile in offspring [57, 58].”
BackgroundPaternal adverse childhood experiences: Associations with infant DNA methylation
Merrill, S. M., Moore, S. R., Gladish, N., Giesbrecht, G. F., Dewey, D., Konwar, C., MacIssac, J. L., Kobor, M. S., & Letourneau, N. L. (2021) · Developmental Psychobiology · doi:10.1002/dev.22174 · Cited by 42
Kanney, N., Patki, A., Chandler-Laney, P., Garvey, W. T., & Hidalgo, B. A. (2022) · Metabolites · doi:10.3390/metabo12121226 · Cited by 10
“In pregnancies complicated by GDM, one study found over 2000 significant differentially methylated CpG sites in the fetal cord blood of GDM-exposed infants [12].”
Background
Metadata
- Authors
- Weng, X., Liu, F., Zhang, H., Kan, M., Wang, T., Dong, M., & Liu, Y.
- Venue
- Diabetes Research and Clinical Practice
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 142
- Pages
- 10-18
- ISSN
- 0168-8227 (ISSN-L)
- OpenAlex
- W2794584941
- Cited by
- 66
- References
- 6
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genome-wide DNA methylation profiling in infants born to gestational diabetes mellitus. https://app.cochat.ai/papers/10.1016/j.diabres.2018.03.016
- The paper
- Weng, X., Liu, F., Zhang, H., Kan, M., Wang, T., Dong, M., & Liu, Y. (2018). Genome-wide DNA methylation profiling in infants born to gestational diabetes mellitus. Diabetes Research and Clinical Practice. https://doi.org/10.1016/j.diabres.2018.03.016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.